The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Effect of Activation and Inhibition of the Renin-Angiotensin System on Plasma PAI-1
Open accessAbstract
Abstract—Increased plasma renin activity (PRA) has been associated with an increased risk of myocardial infarction (MI), whereas angiotensin-converting enzyme (ACE) inhibition appears to reduce the risk of recurrent MI in patients with left ventricular dysfunction. These observations may be partially explained by an interaction between the renin-angiotensin system (RAS) and fibrinolytic system. To test this hypothesis, we examined the effect of salt depletion on tissue-type plasminogen activator (tPA) antigen and plasminogen activator inhibitor-1 (PAI-1) activity and antigen in normotensive subjects in the presence and absence of quinapril (40 mg BID). Under low (10 mmol/d) and high (200 mmol/d) salt conditions there was significant diurnal variation in PAI-1 antigen and activity and tPA antigen. Morning (8 am through 2 pm) PAI-1 antigen levels were significantly higher during low salt intake compared with high salt intake conditions (ANOVA, F=5.8,P=0.048). PAI-1 antigen correlated with aldosterone (r=0.56,P<10−7) during low salt intake. ACE inhibition significantly decreased 24-hour (ANOVA for 24 hours, F=6.7,P=0.04) and morning (F=24,P=0.002) PAI-1 antigen and PAI-1 activity (F=6.48,P=0.038) but did not alter tPA antigen. Thus, the mean morning PAI-1 antigen concentration was significantly higher during low salt intake than during either high salt intake or low salt intake and concomitant ACE inhibition (22.7±4.6 versus 16.1±3.3 and 16.3±3.7 ng/mL, respectively;P<0.05). This study provides evidence of a direct functional link between the RAS and fibrinolytic system in humans. The data suggest that ACE inhibition has the potential to reduce the incidence of thrombotic cardiovascular events by blunting the morning peak in PAI-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction
Muller, J. E., Stone, P. H., Turi, Z. G., Rutherford, J. D., Czeisler, C. A., Parker, C., Poole, W. K., Passamani, E., Roberts, R., Robertson, T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132103 · Cited by 1,884
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke
Brunner, H. R., Laragh, J. H., Baer, L., Newton, M. A., Goodwin, F. T., Krakoff, L. R., Bard, R. H., & Bühler, F. R. (1972) · New England Journal of Medicine · doi:10.1056/nejm197203022860901 · Cited by 1,093
Plasminogen activator inhibitors
Sprengers, E., & Kluft, C. (1987) · Blood · doi:10.1182/blood.v69.2.381.381 · Cited by 1,009
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 730
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B., & Loskutoff, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6998 · Cited by 543
Vaughan, D. E., Lazos, S. A., & Tong, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117809 · Cited by 530
Self-citationAntiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411
Ridker, P. M., Gaboury, C. L., Conlin, P. R., Seely, E. W., Williams, G. H., & Vaughan, D. E. (1993) · Circulation · doi:10.1161/01.cir.87.6.1969 · Cited by 400
Self-citationDiurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).
Angleton, P., Chandler, W. L., & Schmer, G. (1989) · Circulation · doi:10.1161/01.cir.79.1.101 · Cited by 392
PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events
Juhan-Vague, I., & Alessi, M. C. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657607 · Cited by 384
Verheijen, J. H., Chang, G. T. G., & Kluft, C. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661109 · Cited by 338
Hollenberg, N. K., Chenitz, W. R., Adams, D. F., & Williams, G. H. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107748 · Cited by 333
Self-citationKerins, D. M., Hao, Q., & Vaughan, D. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118312 · Cited by 304
Self-citationRidker, P. M., Manson, J. E., Buring, J. E., Muller, J. E., & Hennekens, C. H. (1990) · Circulation · doi:10.1161/01.cir.82.3.897 · Cited by 285
Vaughan, D. E., Rouleau, J.-L., Ridker, P. M., Arnold, J. M. O., Menapace, F. J., & Pfeffer, M. A. (1997) · Circulation · doi:10.1161/01.cir.96.2.442 · Cited by 265
Self-citation(1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90290-5 · Cited by 246
Holmes, C., Eisenhofer, G., & Goldstein, D. S. (1994) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(93)e0430-x · Cited by 226
van Zonneveld, A. J., Curriden, S. A., & Loskutoff, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5525 · Cited by 215
Effects of Captopril on Atherosclerosis in Cynomolgus Monkeys
Aberg, G., & Ferrer, P. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000005-00010 · Cited by 196
Tissue plasminogen activator release in vivo in response to vasoactive agents
Smith, D., Gilbert, M., & Owen, W. (1985) · Blood · doi:10.1182/blood.v66.4.835.835 · Cited by 179
Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man
Oelkers, W., Brown, J., Fraser, R., Lever, A., Morton, J., & Robertson, J. (1977) · Circulation Research · doi:10.1161/01.res.40.4.69 · Cited by 174
Selective Stimulation of Tissue-Type Plasminogen Activator (t-PA) In Vivo by Infusion of Bradykinin
Brown, N. J., Nadeau, J., & Vaughan, D. E. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656000 · Cited by 145
Self-citationWright, R. A., Flapan, A. D., Alberti, K. G. M. M., Ludlam, C. A., & Fox, K. A. A. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90543-6 · Cited by 139
The angiotensin I converting enzyme.
Erdös, E. G. (1977) · PubMed · Cited by 124
Circadian Variation in the Efficacy of Tissue-Type Plasminogen Activator
Kurnik, P. B. (1995) · Circulation · doi:10.1161/01.cir.91.5.1341 · Cited by 118
Hamdan, A. D., Quist, W. C., Gagne, J. B., & Feener, E. P. (1996) · Circulation · doi:10.1161/01.cir.93.6.1073 · Cited by 92
Kim, D., Kim, J., Kim, S., Gwon, H., Ryu, J.-C., Huh, J., Choo, J., Choi, Y.-R., Rhee, C.-H., & Lee, W.-R. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3242 · Cited by 79
Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Manson, J. E., Shen, C., Newcomer, L. M., Goldhaber, S. Z., & Hennekens, C. H. (1992) · Circulation · doi:10.1161/01.cir.85.5.1822 · Cited by 77
Self-citationMargaglione, M., Grandone, E., Vecchione, G., Cappucci, G., Giuliani, N., Colaizzo, D., Celentano, E., Panico, S., & Minno, G. D. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2082 · Cited by 77
Use of First-Dose Response or Plasma Renin Activity to Predict the Long-Term Effect of Captopril
Case, D. B., Atlas, S. A., Laragh, J. H., Sullivan, P. A., & Sealey, J. E. (1980) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198007000-00001 · Cited by 52
Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects.
Workman, R. J., Sussman, C., Burkitt, D. W., & Liddle, G. W. (1979) · PubMed · Cited by 52
Heaton, J. H., Kathju, S., & GELEHRTER, T. D. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.1.1738371 · Cited by 42
Brown, N. J., Ryder, D., Gainer, J. V., Morrow, J. D., & Nadeau, J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21179-x · Cited by 34
Self-citationInsulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity
Chandler, W. L., Mornin, D., Whitten, R. O., Angleton, P., Farin, F. M., Fritsche, T. R., Veith, R. C., & Stratton, J. R. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90238-8 · Cited by 31
On the role of bradykinin in secretion from vascular endothelial cells.
EMEIS, J. J., & Tranquille, N. (1992) · PubMed · Cited by 30
Keidar, S., Hayek, T., & Breslow, J. L. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)96529-2 · Cited by 3
Cited by
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Authors/Task Force Members:, Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,384
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
Metadata
- Authors
- Brown, N. J., Agirbasli, M. A., Williams, G. H., Litchfield, W. R., & Vaughan, D. E.
- Venue
- Hypertension
- Published
- 1998-12
- Volume
- 32
- Issue
- 6
- Pages
- 965-971
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2148688310
- Cited by
- 269
- References
- 41
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.